Eric Lefkofsky, CEO and founder of Tempus AI, explains to Scottish Mortgage manager Tom Slater the huge potential in personalising cancer diagnosis and treatment at scale. Capital at risk.
Tempus AI (NASDAQ: TEM) is utilizing artificial intelligence to deliver better healthcare outcomes. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best ...
Private Advisor Group LLC bought a new position in shares of Tempus AI, Inc. (NASDAQ:TEM – Free Report) during the fourth ...
Artificial intelligence tools continue to be a focal point among publicly traded digital health companies looking to improve ...
Eli Lilly and Company, Hims & Hers Health, UnitedHealth Group, Walmart, Tempus AI, Johnson & Johnson, and Merck & Co., Inc. are the seven Medical stocks to watch today, according to MarketBeat’s stock ...
A remarkable start to the year, marked by a 160% surge, has had investors paying close attention to healthcare tech company ...
In a regulatory filing, Tempus AI (TEM) disclosed that its CEO Eric Lefkofsky disposed of 3.24M shares of company stock in a series of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback